Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy11See Editorial by Cattran, p. 349.
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 61 (1) , 219-227
- https://doi.org/10.1046/j.1523-1755.2002.00124.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Management of idiopathic membranous nephropathy: Evidence-based recommendationsKidney International, 1999
- Prognostic factors in idiopathic membranous nephropathyAmerican Journal of Kidney Diseases, 1998
- Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implicationsKidney International, 1997
- A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathyKidney International, 1995
- Prognosis of Untreated Patients with Idiopathic Membranous NephropathyNew England Journal of Medicine, 1993
- Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritisKidney International, 1992
- Methylprednisolone plus Chlorambucil as Compared with Methylprednisolone Alone for the Treatment of Idiopathic Membranous NephropathyNew England Journal of Medicine, 1992
- Idiopathic membranous nephropathy: The natural history of untreated patientsKidney International, 1988
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984
- Long-term prognosis of idiopathic membranous glomerulonephritisThe American Journal of Medicine, 1979